CARDIOVASCULAR AND PHARMACOKINETIC CONSEQUENCES OF COMBINED ADMINISTRATION OF VERAPAMIL AND PROPRANOLOL IN DOGS

被引:16
作者
HAMANN, SR
KALTENBORN, KE
VORE, M
TAN, TG
MCALLISTER, RG
机构
[1] VET ADM MED CTR,RES SERV,LEXINGTON,KY 40511
[2] UNIV KENTUCKY,COLL MED,DEPT MED,LEXINGTON,KY 40506
[3] UNIV KENTUCKY,COLL MED,DEPT PHARMACOL,LEXINGTON,KY 40506
关键词
D O I
10.1016/0002-9149(85)90584-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:147 / 156
页数:10
相关论文
共 33 条
[1]   SIMPLE AND RAPID-DETERMINATION OF PROPRANOLOL AND ITS ACTIVE METABOLITE, 4-HYDROXYPROPRANOLOL, IN HUMAN-PLASMA BY LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
ALBANI, F ;
RIVA, R ;
BARUZZI, A .
JOURNAL OF CHROMATOGRAPHY, 1982, 228 (MAR) :362-365
[2]  
BUHLER FR, 1982, J CARDIOVASCULAR PHA, V4, P350
[3]  
EICHELBAUM M, 1979, DRUG METAB DISPOS, V7, P145
[4]   EFFECTS OF VERAPAMIL ON P-R-INTERVALS IN RELATION TO VERAPAMIL PLASMA-LEVELS FOLLOWING SINGLE IV AND ORAL-ADMINISTRATION AND DURING CHRONIC TREATMENT [J].
EICHELBAUM, M ;
BIRKEL, P ;
GRUBE, E ;
GUTGEMANN, U ;
SOMOGYI, A .
KLINISCHE WOCHENSCHRIFT, 1980, 58 (18) :919-925
[5]   CLINICAL RELEVANCE OF VERAPAMIL PLASMA-LEVELS IN STABLE ANGINA-PECTORIS [J].
FRISHMAN, W ;
KIRSTEN, E ;
KLEIN, M ;
PINE, M ;
JOHNSON, SM ;
HILLIS, LD ;
PACKER, M ;
KATES, R .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 50 (05) :1180-1184
[6]  
GUGLER R, 1980, BRIT J CLIN PHARMACO, V10, P337
[7]  
HAMANN SR, 1984, J PHARMACOL EXP THER, V231, P301
[8]   PLASMA-CONCENTRATIONS AND HEMODYNAMIC-EFFECTS OF NIFEDIPINE - A STUDY IN ANESTHETIZED DOGS [J].
HAMANN, SR ;
MCALLISTER, RG .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (06) :920-927
[9]   EFFECTS OF PHENOBARBITAL AND SKF-525A ON INVITRO HEPATIC-METABOLISM OF VERAPAMIL AND NIFEDIPINE [J].
HAMANN, SR ;
TAN, TG ;
KALTENBORN, KE ;
BROUWER, KLR ;
BLOUIN, RA ;
CHANG, SL ;
VORE, M ;
MCALLISTER, RG .
PHARMACOLOGY, 1985, 30 (03) :121-128
[10]  
HAMANN SR, 1985, J CARDIOVASC PHARM